Cytek Biosciences CTO Yan Ming Reports Gift of 135,892 Shares

Yan Ming, Chief Technology Officer and Director of Cytek Biosciences, Inc. (CTKB), filed a Form 4 on June 16, 2026, reporting a gift transaction of 135,892 shares of common stock on June 12, 2026. The shares were disposed of at $0.00 per share, indicating a non-sale transfer such as a gift or charitable donation. Following this transaction, Ming's remaining ownership stands at 4,796,688 shares. The filing represents a routine disclosure of insider transactions required by SEC regulations for officers and directors. The transaction code "G" specifically indicates a bona fide gift, which is a common method for executives to transfer shares to family members, trusts, or charitable organizations while maintaining transparency about their changing ownership positions in the company.